Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.67 AUD | -2.19% | +26.42% | +25.23% |
Apr. 17 | Recce Pharmaceuticals Ltd. Completes 5,000 RECCE 327 Doses Week Under Good Manufacturing Practice | CI |
Apr. 16 | Recce Pharmaceuticals Advances Production of Anti-Infective Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.23% | 90.87M | |
+25.97% | 653B | |
+27.00% | 556B | |
-6.39% | 354B | |
+20.60% | 331B | |
+3.91% | 296B | |
+13.08% | 233B | |
+5.59% | 201B | |
-9.49% | 193B | |
-6.35% | 144B |
- Stock Market
- Equities
- RCE Stock
- News Recce Pharmaceuticals Ltd
- Recce Pharmaceuticals Doses Human Subjects in RECCE 327 Clinical Trial